Ether compounds and compositions for cholesterol management and related uses
CA 2425121 A1 · Owner: Esperion Therapeutics, Inc. · Inventors: Dasseux, Jean-Louis H.; Oniciu, Carmen Daniela
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel ether compounds compositions , comprising ether compounds and methods useful for treating and preventing cardiovascular diseases, dyslipidemias dysproteinemias, and glucose , metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions and methods of the invention are , also useful for treating and preventing Alzheimer's Disease Syndrome X, peroxisome proliferator activated receptor-related disorders septicemia, thrombotic disorders, obesity pancreatitis, hypertension, renal disease cancer, inflammation, and impotence. In certain embodiments the compounds, compositions, and methods of the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.